We are live on ! Find out more
MIM

Martin Investment Management Portfolio holdings

AUM $300M
1-Year Est. Return 6.05%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+6.05%
3 Year Est. Return
+44.71%
5 Year Est. Return
+50.94%
10 Year Est. Return
+276.43%
AUM
$336M
AUM Growth
+$1.95M
Cap. Flow
-$22.7M
Cap. Flow %
-6.75%
Top 10 Hldgs %
59.09%
Holding
53
New
5
Increased
2
Reduced
32
Closed
5

Top Buys

Rank Stock Value
1
AME icon
Ametek
AME
+$6.53M
2
ADBE icon
Adobe
ADBE
+$6.34M
3
WAB icon
Wabtec
WAB
+$5.95M
4
HLN icon
Haleon
HLN
+$304K
5
ICLR icon
Icon
ICLR
+$191K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$6.78M
2
CARR icon
Carrier Global
CARR
+$6.11M
3
BMY icon
Bristol-Myers Squibb
BMY
+$5.7M
4
RTX icon
RTX Corp
RTX
+$3.58M
5
FMC icon
FMC
FMC
+$3.46M

Sector Composition

Rank Sector Weight
1 Technology 30.62%
2 Healthcare 28.68%
3 Financials 11.03%
4 Industrials 10.72%
5 Consumer Discretionary 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
51
GSK
GSK
$102B
-25,728
Closed -$933K
JNJ icon
52
Johnson & Johnson
JNJ
$624B
-43,525
Closed -$6.78M
RTX icon
53
RTX Corp
RTX
$302B
-49,808
Closed -$3.58M

Similar funds

Martin Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Martin Investment Management held 53 positions worth $336M, up 0.58% from $334M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Martin Investment Management withdrew a net $22.7M in Q4 2023, closing 5 positions and reducing 32 holdings. Its most notable exit was Johnson & Johnson, an estimated $6.78M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Martin Investment Management opened a new position in Ametek worth $7.07M.

  • Martin Investment Management's largest Q4 2023 buy was Ametek: 42,857 shares worth $7.07M.
  • Martin Investment Management added most to Medtronic in Q4 2023, an estimated $76.1K increase.
  • Martin Investment Management's biggest Q4 2023 reduction was Bristol-Myers Squibb, cutting an estimated $5.7M.
  • Martin Investment Management fully exited Johnson & Johnson in Q4 2023, selling an estimated $6.78M.
  • Martin Investment Management's ten largest holdings make up 59% of its $336M portfolio in Q4 2023.
  • Martin Investment Management opened 5 new positions and closed 5 in Q4 2023.
  • Martin Investment Management's portfolio value rose 0.58% quarter-over-quarter to $336M.

Based on Martin Investment Management's 13F filing for Q4 2023, filed 6 Feb 2024.